Piper Sandler upgrades Biogen, says Alzheimer's drug demand will be strong despite controversy
June 18, 2021 at 06:57 AM EDT
The FDA's approval of Aduhelm has been controversial, with multiple members of an advisory committee resigning in protest over the decision.
